{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:59:54Z","timestamp":1793480394020,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1136\/ard.2009.117200","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T01:40:26Z","timestamp":1257471626000},"page":"1269-1274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":308,"title":["European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies"],"prefix":"10.1016","volume":"69","author":[{"given":"M","family":"Mosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O P","family":"Rekvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Sherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"van Vollenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V P","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.117200_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.24356","article-title":"Systemic Lupus Erythematosus Quality Indicators Project Expert Panels. A quality indicator set for systemic lupus erythematosus","volume":"61","author":"Yazdany","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/BOR.0b013e328323daad","article-title":"Disparities in lupus care and outcomes","volume":"21","author":"Demas","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2009.117200_bib3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117200_bib4","unstructured":"Centre for Evidence-Based Medicine. EBM Tools. Finding the Evidence. Levels of Evidence. University of Oxford, 2001. http:\/\/www.cebm.net\/index.aspx?o=1025, (accessed 15 February 2009)."},{"key":"10.1136\/ard.2009.117200_bib5","first-page":"490","article-title":"Outcome measures to be used in clinical trials in systemic lupus erythematosus","volume":"26","author":"Strand","year":"1999","journal-title":"J Rheumatol"},{"issue":"5 Suppl","key":"10.1136\/ard.2009.117200_bib6","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1002\/art.11402","article-title":"Systemic lupus erythematosus measures","volume":"49","author":"Ramsey-Goldman","year":"2003","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard.2009.117200_bib7","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/art.21149","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients","volume":"52","author":"Calvo-Al\u00e9n","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib8","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.117200_bib9","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study","volume":"48","author":"Bruce","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib10","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keg436","article-title":"Prevention of cardiovascular disease in systemic lupus erythematosus \u2013 proposed guidelines for risk factor management","volume":"43","author":"Wajed","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.117200_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/kem105","article-title":"Prevalence and risk factors of osteoporosis in female SLE patients-extended report","volume":"46","author":"Almehed","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.117200_bib14","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.21110","article-title":"Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus","volume":"52","author":"Bultink","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117200_bib16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib17","first-page":"1763","article-title":"Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide","volume":"31","author":"Ognenovski","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.117200_bib18","first-page":"45","article-title":"Cancer screening in patients with systemic lupus erythematosus","volume":"33","author":"Bernatsky","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.117200_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1191\/0961203306lu2289xx","article-title":"High risk of tuberculosis in systemic lupus erythematosus?","volume":"15","author":"Erdozain","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2009.117200_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/096120339700600612","article-title":"Hepatitis B and C viruses serology in patients with SLE","volume":"6","author":"Abu-Shakra","year":"1997","journal-title":"Lupus"},{"key":"10.1136\/ard.2009.117200_bib21","unstructured":"http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00001642.htm."},{"key":"10.1136\/ard.2009.117200_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/s10165-006-0470-x","article-title":"Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia","volume":"16","author":"Yoda","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1136\/ard.2009.117200_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MD.0b013e31818ec711","article-title":"Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2009.117200_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157339707779815821","article-title":"Vaccination and rheumatic diseases: is there still a dilemma?","volume":"3","author":"Conti","year":"2007","journal-title":"Curr Rheumatol Rev"},{"key":"10.1136\/ard.2009.117200_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T","article-title":"Antigen-specific antibody responses in lupus patients following immunization","volume":"41","author":"Battafarano","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/art.1780221201","article-title":"A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus","volume":"22","author":"Klippel","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/qjmed\/hci155","article-title":"Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus","volume":"99","author":"Ng","year":"2006","journal-title":"QJM"},{"key":"10.1136\/ard.2009.117200_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000234648","article-title":"Relation between the level of IgG subclasses and infections in patients with systemic lupus erythematosus","volume":"87","author":"Tokano","year":"1988","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1136\/ard.2009.117200_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2003.013417","article-title":"Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus","volume":"63","author":"Hoffman","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117200_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.10558","article-title":"Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests","volume":"47","author":"Kavanaugh","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117200_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1136\/ard.2009.117200_bib33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1191\/0961203304lu2030oa","article-title":"Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus","volume":"13","author":"Ruiz-Irastorza","year":"2004","journal-title":"Lupus"},{"key":"10.1136\/ard.2009.117200_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","article-title":"Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis","volume":"43","author":"Moroni","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/ard.2009.117200_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0049-0172(97)80033-9","article-title":"Outcome of renal transplantation in systemic lupus erythematosus","volume":"27","author":"Stone","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib36","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A","article-title":"A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0961203308100481","article-title":"European consensus statement on the terminology used in the management of lupus glomerulonephritis","volume":"18","author":"Gordon","year":"2009","journal-title":"Lupus"},{"key":"10.1136\/ard.2009.117200_bib38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/art.10138","article-title":"Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine","volume":"46","author":"Mok","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib39","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.20364","article-title":"Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis","volume":"50","author":"Mok","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib40","first-page":"454","article-title":"Studies of serum C-reactive protein in systemic lupus erythematosus","volume":"32","author":"Williams","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.117200_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","article-title":"Lupus erythematosus: systemic and cutaneous manifestations","volume":"24","author":"Rothfield","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1136\/ard.2009.117200_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/art.23319","article-title":"The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatology","volume":"59","author":"Krathen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib43","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/art.1780391212","article-title":"Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide","volume":"39","author":"Ciruelo","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/art.10142","article-title":"Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies","volume":"46","author":"Illei","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib45","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/ki.1996.528","article-title":"\u201cNephritic flares\u201d are predictors of bad long-term renal outcome in lupus nephritis","volume":"50","author":"Moroni","year":"1996","journal-title":"Kidney Int"},{"key":"10.1136\/ard.2009.117200_bib46","first-page":"1006","article-title":"How \u201csoft\u201d are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus","volume":"30","author":"Denburg","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.117200_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"56","author":"Hanly","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117200_bib48","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0161-6420(03)00409-3","article-title":"The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal","volume":"110","author":"Mavrikakis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1136\/ard.2009.117200_bib49","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","author":"Ruiz-Irastorza","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117200_bib50","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724194137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724194137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.117200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T14:06:07Z","timestamp":1736085967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724194137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0003496724194137"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.117200","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.117200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}